Skip to content

A Clinical Trial to Evaluate the Effects of a Supplement on Markers of Male Fertility

A Clinical Trial to Evaluate the Effects of a Supplement on Markers of Male Fertility

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07740161
Enrollment
40
Registered
2026-07-31
Start date
2025-04-14
Completion date
2025-09-15
Last updated
2026-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Energy, Low Libido, Low Sperm Quality, Low Testosterone, Male Infertility

Brief summary

This study will evaluate the effects of the WeNatal For Him supplement on markers of male fertility over a 3-month period. The trial is a single-arm, unblinded study enrolling 40 male participants who will take 3 capsules of the test product daily in the morning with their first meal. Participants will complete questionnaires at Baseline, Month 1, Month 2, and Month 3. Semen analysis will be conducted at home at Baseline and Month 3, and blood testing will be performed at a local Labcorp location at Baseline and Month 3. The primary focus is on sperm quality parameters and testosterone levels, while secondary endpoints capture participants' perceptions of changes in reproductive and sexual health, including energy and libido.

Interventions

DIETARY_SUPPLEMENTWeNatal For Him Supplement

All participants take 3 capsules of the WeNatal For Him supplement daily in the morning with their first meal for 3 months.

Sponsors

WeNatal
Lead SponsorINDUSTRY
Citruslabs
CollaboratorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Be male * Be aged 30+ * Anyone currently experiencing issues regarding low energy and low libido * Anyone who is generally healthy - does not live with any uncontrolled chronic disease * Willing to stop taking any other products or prescription medication, herbal remedies, or supplements for the duration of the study that target fertility, reproductive health, and sexual health * Not planning on introducing any products or any new prescription medication, herbal remedies, or supplements that target male fertility, reproductive health, or sexual health for the study duration * Resides in the United States * Not currently partaking in another research study and will not be partaking in any other research study for the next 3 months and at any point during this study's duration * Willing to provide a semen sample via masturbation * Willing to abstain from ejaculation for a minimum of 48 hours and a maximum of 5 days before providing the semen sample * Willing to abstain from marijuana products during the entire study duration

Exclusion criteria

* Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders * Anyone who has ever taken supplemental testosterone * Anyone planning to undergo any surgeries or invasive treatments for the study duration * Anyone who has had a major illness in the last 3 months * Anyone currently undergoing any type of fertility treatment * Anyone with any allergies or sensitivities to any of the study product ingredients * Anyone unwilling to follow the study protocol * Anyone taking anticoagulant or 'blood thinner' medication * Anyone undergoing chemotherapy * Anyone taking insulin or diabetes medication * Anyone who drinks heavily (i.e. 8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men) * Anyone with a history of substance abuse * Anyone who is currently a smoker or has been a smoker in the past 3 months

Design outcomes

Primary

MeasureTime frameDescription
Change in Testosterone (Free and Total)Baseline and Month 3Assessed via blood test at a local Labcorp location measuring free and total testosterone levels
Change in Sperm VolumeBaseline and Month 3Assessed via at-home semen analysis using the Fellow Semen Analysis kit
Change in Sperm ConcentrationBaseline and Month 3Assessed via at-home semen analysis using the Fellow Semen Analysis kit
Change in Sperm CountBaseline and Month 3Assessed via at-home semen analysis using the Fellow Semen Analysis kit
Change in Sperm MotilityBaseline and Month 3Assessed via at-home semen analysis using the Fellow Semen Analysis kit
Change in Total Motile CountBaseline and Month 3Assessed via at-home semen analysis using the Fellow Semen Analysis kit
Change in Sperm MorphologyBaseline and Month 3Assessed via at-home semen analysis using the Fellow Semen Analysis kit
Change in 25-hydroxy Vitamin DBaseline and Month 3Assessed via blood test at a local Labcorp location
Change in hs-CRPBaseline and Month 3Assessed via blood test at a local Labcorp location
Change in HomocysteineBaseline and Month 3Assessed via blood test at a local Labcorp location

Secondary

MeasureTime frameDescription
Change in Self-Reported Reproductive HealthBaseline, Month 1, Month 2, and Month 3Assessed via self-reported questionnaire
Change in Self-Reported EnergyBaseline, Month 1, Month 2, and Month 3Assessed via self-reported questionnaire
Change in Self-Reported LibidoBaseline, Month 1, Month 2, and Month 3Assessed via self-reported questionnaire

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 1, 2026